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Résumé en
anglais
Glioblastoma (GBM), the deadliest primary tumor of the central nervous system
(CNS), is a clear illustration of the resistance of cancer cells to conventional
therapies. Application of combinatorial strategies able to overcome pivotal factors
of GBM resistance, particularly within the resection margins, represents an
essential issue. This review focuses on the role of iron metabolism in GBM
progression and resistance to therapy, and the impact of its pharmaceutical
modulation on the disease. Iron, through its involvement in many biological
processes, is a key factor in the control of cell behavior and cancer biology.
Therefore, targeting cellular iron signaling or taking advantage of its
dysregulation in cancer cells may lead to new opportunities for improving
treatments and drug delivery in GBM.
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